Pronounced Benefit of Coronary Stenting and Adjunctive Platelet Glycoprotein IIb/IIIa Inhibition in Complex Atherosclerotic Lesions

200076 citationsJournal Articlebronze Open Access

Authors

Fernando Cura · Cleveland Clinic

Deepak L. Bhatt · Cleveland Clinic

A. Michael Lincoff · Cleveland Clinic

Samir Kapadia · Cleveland Foundation

Philippe L. L’Allier · Cleveland Clinic

Khaled M. Ziada · Cleveland Clinic

Katherine E. Wolski ·

Abstract

The combination of stenting and abciximab during percutaneous coronary interventions for patients with angiographically complex lesions confers additive long-term benefit with respect to death, myocardial infarction, and target vessel revascularization.

Topics & Keywords

Coronary Interventions and Diagnostics Acute Myocardial Infarction Research Antiplatelet Therapy and Cardiovascular Diseases

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 102, Issue 1, pp. 28-34

DOI: 10.1161/01.cir.102.1.28

Field-Weighted Citation Impact: 10.54